SenguptaV, SenguptaS, Lazo JrA, WoodsP, NolanA and BremerN. (2020). Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19. Stem Cells Dev, 29:747–754.
2.
LimSK, GiebelB, WeissDJ, WitwerKW and RohdeE. (2020). Re: “Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19” by Sengupta et al. Stem Cells Dev, 29:877–878.
3.
WilsonJG, LiuKD, ZhuoH, CaballeroL, McMillanM, FangX, CosgroveK, VojnikR, CalfeeCS, et al. (2015). Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir Med, 3:24–32.
